not tagged
not tagged
['mds', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)']
#eha22 #mdssm meers: delaying progression to aml a controversial endpoint; decitabine demonstrated this. other endpoints relevant to pts include liberation from tfns and improved qol. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)